Advances in targeted therapy for AML: Efficacy and practical management of BCL-2 inhibitors
Meeting Host
AbbVie-Medical AffairsDescription
When
Thursday, September 14, 2023, from 12 - 1 p.m. Eastern Time
Where
This is a Microsoft Teams meeting.
Meeting Facilitator
Nahir Rivera, PharmD, BCOP
Medical Science Liaison,
Hematology
This program is not intended or eligible for continuing education (CME/CE) credits and does not meet guidelines governing CME/CE.